Comparative efficacy and safety of gemigliptin versus linagliptin in type 2 diabetes patients with renal impairment: A 40-week extension of the GUARD randomized study

Sang Youb Han, Sun Ae Yoon, Byoung Geun Han, Sung Gyun Kim, Young Il Jo, Kyung Hwan Jeong, Kook Hwan Oh, Hyeong Cheon Park, Sun Hee Park, Shin Wook Kang, Ki Ryang Na, Sun Woo Kang, Nam Ho Kim, Younghwan Jang, Bogyeong Kim, Seonghye Shin, Dae Ryong Cha

    Research output: Contribution to journalArticlepeer-review

    7 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Comparative efficacy and safety of gemigliptin versus linagliptin in type 2 diabetes patients with renal impairment: A 40-week extension of the GUARD randomized study'. Together they form a unique fingerprint.

    Medicine & Life Sciences